collaboration

Oncology

Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.

Oncology

Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade.

R&D

Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.

Digital

The Basel Area is increasingly becoming a convergence point where life sciences, advanced computing, and health technology intersect.

News

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

Market Access

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.